ARDELYX, INC. Increase (Decrease) in Deferred Revenue
ARDELYX, INC. (ARDX) reported Increase (Decrease) in Deferred Revenue of $5.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-06
- ARDELYX, INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $3.49M.
- ARDELYX, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $2.04M, a 51.82% increase year-over-year.
- ARDELYX, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$5.38M.
- ARDELYX, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $1.71M.
- ARDELYX, INC. increase (decrease) in deferred revenue for fiscal 2025 was -$3.01M, a 244.02% decline from fiscal 2024.
- ARDELYX, INC. increase (decrease) in deferred revenue for fiscal 2024 was $2.09M, a 19.23% decline from fiscal 2023.
- ARDELYX, INC. increase (decrease) in deferred revenue for fiscal 2023 was $2.59M, a 69.56% decline from fiscal 2022.
- ARDELYX, INC. increase (decrease) in deferred revenue for fiscal 2022 was $8.51M, a 1447.09% increase from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.53M 10-Q · filed 2026-08-06 | $157.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.04M 10-Q · filed 2026-04-30 | -$3.33M derived: sum of 2 quarters · filed 2026-04-30 | -$1.63M derived: sum of 3 quarters · filed 2026-04-30 | -$2.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$3.67M derived: sum of 2 quarters · filed 2026-02-19 | -$4.36M derived: sum of 3 quarters · filed 2026-08-06 | -$3.01M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.02M derived: sum of 2 quarters · filed 2026-08-06 | $2.36M 10-Q · filed 2025-10-30 | $238.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $657.00K 10-Q · filed 2026-08-06 | -$1.47M derived: sum of 3 quarters · filed 2026-08-06 | -$1.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.34M 10-Q · filed 2026-04-30 | -$779.00K derived: sum of 2 quarters · filed 2026-04-30 | -$1.18M derived: sum of 3 quarters · filed 2026-04-30 | $574.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.52M derived: sum of 2 quarters · filed 2026-02-19 | -$771.00K derived: sum of 3 quarters · filed 2026-02-19 | $2.09M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.35M derived: sum of 2 quarters · filed 2025-10-30 | $4.22M 10-Q · filed 2025-10-30 | $5.68M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $4.62M 10-Q · filed 2025-08-04 | $6.08M derived: sum of 3 quarters · filed 2026-02-19 | $5.25M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $2.86M 10-Q · filed 2025-05-01 | $4.33M derived: sum of 2 quarters · filed 2026-02-19 | $3.49M derived: sum of 3 quarters · filed 2026-02-19 | $1.65M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $629.00K derived: sum of 2 quarters · filed 2026-02-19 | -$1.22M derived: sum of 3 quarters · filed 2026-02-19 | $2.59M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$835.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$2.68M derived: sum of 2 quarters · filed 2024-10-31 | $1.13M 10-Q · filed 2024-10-31 | $1.80M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.96M 10-Q · filed 2024-08-01 | $2.63M derived: sum of 3 quarters · filed 2025-02-20 | $2.78M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $3.81M 10-Q · filed 2024-05-02 | $4.48M derived: sum of 2 quarters · filed 2025-02-20 | $4.62M derived: sum of 3 quarters · filed 2025-02-20 | $8.48M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $815.00K derived: sum of 2 quarters · filed 2025-02-20 | $4.67M derived: sum of 3 quarters · filed 2025-02-20 | $8.51M 10-K · filed 2025-02-20 |
| 2022-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $4.00M derived: sum of 2 quarters · filed 2023-10-31 | $7.84M 10-Q · filed 2023-10-31 | $9.09M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $7.69M 10-Q · filed 2023-08-02 | $8.95M derived: sum of 3 quarters · filed 2024-02-22 | $8.06M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $3.84M 10-Q · filed 2023-05-03 | $5.09M derived: sum of 2 quarters · filed 2024-02-22 | $4.20M derived: sum of 3 quarters · filed 2024-02-22 | $5.84M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $368.00K derived: sum of 2 quarters · filed 2024-02-22 | $2.00M derived: sum of 3 quarters · filed 2024-02-22 | $550.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | -$885.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $751.00K derived: sum of 2 quarters · filed 2022-11-03 | -$703.00K 10-Q · filed 2022-11-03 | $2.59M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $182.00K 10-Q · filed 2022-08-04 | $3.47M derived: sum of 3 quarters · filed 2023-03-02 | $2.12M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$1.45M 10-Q · filed 2022-05-05 | $1.84M derived: sum of 2 quarters · filed 2023-03-02 | $482.00K derived: sum of 3 quarters · filed 2023-03-02 | -$643.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.94M derived: sum of 2 quarters · filed 2023-03-02 | $811.00K derived: sum of 3 quarters · filed 2023-03-02 | -$364.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$2.48M derived: sum of 2 quarters · filed 2021-11-12 | -$3.66M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$2.30M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$1.18M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $4.54M 10-K · filed 2022-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | -$43.14M derived: sum of 3 quarters · filed 2018-03-14 | -$47.05M 10-K · filed 2018-03-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$43.14M derived: sum of 2 quarters · filed 2016-11-07 | -$47.05M 10-Q · filed 2016-11-07 | -$51.44M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$43.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$47.05M 10-Q · filed 2016-08-08 | -$51.44M derived: sum of 3 quarters · filed 2017-02-17 | -$56.39M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$3.91M 10-Q · filed 2016-05-09 | -$8.30M derived: sum of 2 quarters · filed 2017-02-17 | -$13.25M derived: sum of 3 quarters · filed 2017-02-17 | $5.28M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$9.34M derived: sum of 2 quarters · filed 2017-02-17 | $9.19M derived: sum of 3 quarters · filed 2017-02-17 | $6.75M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $13.57M derived: sum of 2 quarters · filed 2015-11-12 | $11.14M 10-Q · filed 2015-11-12 | $23.97M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $18.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $16.09M 10-Q · filed 2015-08-12 | $28.92M derived: sum of 3 quarters · filed 2016-03-04 | $26.59M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | -$2.43M 10-Q · filed 2015-05-12 | $10.39M derived: sum of 2 quarters · filed 2016-03-04 | $8.06M derived: sum of 3 quarters · filed 2016-03-04 | |
| 2013-12-31 | $12.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $10.50M derived: sum of 2 quarters · filed 2016-03-04 | $7.64M 10-K · filed 2016-03-04 | |
| 2013-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$5.19M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$2.86M 10-Q · filed 2014-08-08 | |||
| 2012-12-31 | $32.66M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |